A neuroscientist with a PhD and post-doc from UCL in linguistics, neuroscience and psychology, Emilia is one of fewer than 10 researchers worldwide working at that intersection and has spent a decade using language as a biomarker for cognition. A TED speaker and Fortune 40 Under 40 leader, Emilia co-founded thymia to turn that science into a product.

A theoretical physicist who spent over 8 years as a quantitative analyst at J.P. Morgan and Citi, 17 years have been spent bringing cutting-edge mathematical models into production. A co-founder of thymia, Stefano leads the engineering and ML research teams, applying that work to one of the biggest health problems of our time.

A psychologist, neuroscientist and former Assistant Professor at King's College London, Alexandra manages external stakeholders; obtained grant funding and led studies on longitudinal voice biomarkers in depression and in shift workers, focusing on making health assessment more accessible. She now leads thymia's Science team and the clinical validation strategy behind its voice biomarker technology.

A cognitive neuroscientist with computational psychiatry fellowships at the University of Cambridge, Mount Sinai and UCL, Agnes’ passion is improving health outcomes. She has built the clinical validity of thymia's depression and anxiety model, scaled its data set past 75,000 speakers and led the AI Quality taskforce. Her work sits where psychological science meets machine learning.

A cognitive neuroscientist and award-winning science communicator formerly at King's College London, Elisa has pioneered EEG integration into thymia's methods and designed its most complex real-world validation studies, from in-vehicle data collection to large-scale diabetes research. Elisa also built thymia's clinical advisor community.

A cognitive neuroscientist trained at the University of Oxford with postdoctoral experience validating digital technologies for early dementia detection at UCL, Giedre now leads projects extending thymia's tools into new territory, including new geographies, automotive industry and physical health. Research that reaches real-world scale is of particular interest.

A neuropsychologist with a PhD from King's College London, data scientist and postdoc in global digital health. Ayla has designed longitudinal and cross-sectional digital health interventions, evaluated wearable data for remote monitoring and developed risk and governance frameworks for responsible human-AI interaction. At thymia she works on wearable technology and conversational data collection.

A cognitive neuroscientist with a PhD from Cambridge who has led machine learning teams across autonomous vehicles, healthcare AI and human-AI interaction, Owen now steers the technical direction of thymia's ML team. Work centres on model development, evaluation and interpretability, and on turning research into commercial impact.

A researcher with a PhD in mathematics and computer science and nearly a decade of experience across computer vision, generative AI and neuroimaging, Konstantin leads thymia's work on the audio representations underlying its vocal biomarkers and built the LLM voice agents running patient check-ins on NHS waiting lists.

An engineer with master's degrees from École Polytechnique, Imperial and UCL who audited AI systems at Holistic AI, Roseline has developed a novel model that detects diabetes from speech and published several times at Interspeech. At thymia, the model capability is extended across clinical domains and languages, focusing on bias and interpretability.

An engineer and cognitive scientist by training, George has helped design, train and evaluate thymia's core biomarker models and contributed to clinically publishable research. Work spans the full model lifecycle, from experimental design and validation through to production, keeping models at the bar clinical use demands.

A physicist with 4 years of computational research across astronomy and healthcare, Luis has built the data pipelines behind thymia's research and the company-wide dashboard used daily across the organisation, and delivered the production thresholds that flag poor-quality recordings. His work turns raw data into something the company can act on.

Formerly Director of Engineering at Cazana and Head of Engineering at Cazoo following its acquisition, Martin has spent a career in AI start-ups taking concepts from first idea through to production. At thymia, the engineering team is led across data, product and platform, working closely with the ML and science teams.

An ML Ops engineer with over a decade across the machine learning and software lifecycles, Jack has productionised thymia's data products and built the MLOps platforms behind its larger-scale systems. The role works between the engineering and ML teams, keeping research models reliable in production.

A software engineer with over 8 years experience across the full stack, David has built thymia's real-time voice AI agent systems and Lyra, its audio streaming and analysis server, and led the infrastructure and security work behind its SOC 2 and HIPAA compliance. His work is focused where real-time voice meets AI.

An engineer who built BAFTA-winning broadcast software at ChyronHego and medical imaging systems at Perspectum in Oxford, Greg has strengthened the backend and frontend of the platform behind thymia's assessments and contributed to its voice agent technology. The focus is reliability at scale.

A product designer and engineer with 7 years' experience and one of thymia's longest-serving team members, Danny led the front-end and design of multiple thymia products and now leads the company's rebrand for a new generation of thymia. A passion for pushing what an engaging mental health experience can be drives the work.

Stella leads strategic communications at thymia. A biology PhD trained at Oxford and Cambridge, she works at the intersection of research, company-building and communications, including in voice AI as early as 2019. She has built programmes for techbio, deep tech and healthcare companies at every stage, from stealth to listed, spanning positioning, thought leadership and key announcements.

A Chartered Accountant and strategic partner to the CEO, Nivi leads thymia's finance function across investor relations, fundraising, treasury and FP&A, and built the compliance frameworks covering tax, payroll, risk and R&D incentives. The role balances financial discipline with the pragmatism fast growth demands.

A former Metropolitan Police Detective Constable specialising in domestic violence who began a career in health tech, Madeleine now leads thymia's people function, building the culture behind its retention, wellbeing and performance through a period of fast growth. A CIPD Level 5 qualification in People Management is held, and study is ongoing towards Level 7.

A pharmacist and BSI Certified Medical Device Professional with a Master's in Global Logistics & Supply Chain Management, Abisola is responsible for establishing and maintaining thymia's multiple regulatory & compliance frameworks. Also a certified ISO 27001 and ISO 13485 auditor, Abisola manages the ISMS and QMS, leads internal and external audits, and supports multi-jurisdiction regulatory pathways.

A Finance postgraduate from King's College London, Anushna supports thymia's finance function across FP&A, cash management, investor reporting and operational governance. Strategic initiatives spanning intellectual property, business insurance and banking are led, bridging financial insight with operational execution.

A former Medical Science Liaison at Novartis and facilitator of life sciences startups entering the Japan market at JETRO, the Japanese government's trade organisation, Tatsuya is scaling thymia's operations in Japan, driving partnerships across a range of Japanese enterprise sectors and shaping the technology to fit Japanese clinical and regulatory demands.

A business advisor with over 30 years' experience, Tomo has guided Japanese companies into overseas markets and brought deep tech start-ups from the US, Europe and Israel into Japan across automotive, telecom, electronics and fintech. Advice is provided on thymia's Japanese launch in automotive and pharma.